Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial

Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial

<b>Objective:</b> This study aimed to assess the bioequivalence of two oral methocarbamol formulations, as follows: the test (T) methocarbamol 1500 mg tablets and the reference (R) Robaxin<sup>®</sup> 500 mg tablets (3 tablets, total dose: 1500 mg) under fasting conditions, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Ascaso-del-Rio, Paola Camargo-Mamani, Inmaculada Gilaberte, Mónica Díez-Hochleitner, Leonor Laredo-Velasco, Teresa Iglesias-Hernangómez, María Rosario Salas-Butrón, Laura Galán Caballero, Iván Alejandro Díaz-Rengifo, Carla Pérez-Ingidua, Emilio Vargas-Castrillón, Antonio Portolés-Pérez
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmaceuticals
Subjects:
Robaxin
methocarbamol
bioequivalence
bioequivalence study
methocarbamol pharmacokinetics
methocarbamol bioequivalence
Online Access:https://www.mdpi.com/1424-8247/18/3/354
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/3/354

Similar Items